These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
229 related items for PubMed ID: 33591553
1. Long-term safety and efficacy of hydroxychloroquine in patients with IgA nephropathy: a single-center experience. Tang C, Lv JC, Shi SF, Chen YQ, Liu LJ, Zhang H. J Nephrol; 2022 Mar; 35(2):429-440. PubMed ID: 33591553 [Abstract] [Full Text] [Related]
2. Effects of Hydroxychloroquine on Proteinuria in IgA Nephropathy: A Randomized Controlled Trial. Liu LJ, Yang YZ, Shi SF, Bao YF, Yang C, Zhu SN, Sui GL, Chen YQ, Lv JC, Zhang H. Am J Kidney Dis; 2019 Jul; 74(1):15-22. PubMed ID: 30922594 [Abstract] [Full Text] [Related]
3. Comparison of the effects of hydroxychloroquine and corticosteroid treatment on proteinuria in IgA nephropathy: a case-control study. Yang YZ, Chen P, Liu LJ, Cai QQ, Shi SF, Chen YQ, Lv JC, Zhang H. BMC Nephrol; 2019 Aug 05; 20(1):297. PubMed ID: 31382914 [Abstract] [Full Text] [Related]
4. Comparison between hydroxychloroquine and systemic corticosteroids in IgA nephropathy: a two-year follow-up study. Si FL, Tang C, Lv JC, Shi SF, Zhou XJ, Liu LJ, Zhang H. BMC Nephrol; 2023 Jun 15; 24(1):175. PubMed ID: 37322444 [Abstract] [Full Text] [Related]
5. Efficacy and Safety of Hydroxychloroquine in Patients with IgA Nephropathy: A Meta-Analysis. Zhang Z, Liu X, Ye P, Xie C, Kong Y. Arch Esp Urol; 2024 Jan 15; 77(1):16-24. PubMed ID: 38374008 [Abstract] [Full Text] [Related]
6. Efficacy of corticosteroid therapy for IgA nephropathy patients stratified by kidney function and proteinuria. Nagasawa Y, Yamamoto R, Shinzawa M, Shoji T, Hasuike Y, Nagatoya K, Yamauchi A, Hayashi T, Kuragano T, Moriyama T, Isaka Y. Clin Exp Nephrol; 2020 Oct 15; 24(10):927-934. PubMed ID: 32642919 [Abstract] [Full Text] [Related]
7. The efficacy and safety of hydroxychloroquine in pregnant patients with IgA nephropathy: A retrospective cohort study. Tang C, Si FL, Yao YX, Lv JC, Shi SF, Chen YQ, Liu LJ, Zhang H. Nephrology (Carlton); 2022 Feb 15; 27(2):155-161. PubMed ID: 34713949 [Abstract] [Full Text] [Related]
8. The efficacy and safety of hydroxychloroquine versus leflunomide in patients with IgA nephropathy: a single-center experience. He WJ, Wang J, Liu N, Li GY, Zhu XW, Yao L, Liu LL. J Nephrol; 2024 May 15; 37(4):933-940. PubMed ID: 38225440 [Abstract] [Full Text] [Related]
9. Effects of Hydroxychloroquine on Proteinuria in Immunoglobulin A Nephropathy. Yang YZ, Liu LJ, Shi SF, Wang JW, Chen YQ, Lv JC, Zhang H. Am J Nephrol; 2018 May 15; 47(3):145-152. PubMed ID: 29502121 [Abstract] [Full Text] [Related]
10. Hydroxychloroquine in IgA nephropathy: a systematic review. Stefan G, Mircescu G. Ren Fail; 2021 Dec 15; 43(1):1520-1527. PubMed ID: 34779707 [Abstract] [Full Text] [Related]
11. Hydroxychloroquine alleviates persistent proteinuria in IgA nephropathy. Gao R, Wu W, Wen Y, Li X. Int Urol Nephrol; 2017 Jul 15; 49(7):1233-1241. PubMed ID: 28349446 [Abstract] [Full Text] [Related]
12. Effect of hydroxychloroquine in patients with IgA nephropathy with insufficient responses to immunosuppressive therapy: a retrospective case-control study. Tang C, Lv JC, Shi SF, Chen YQ, Liu LJ, Zhang H. BMC Nephrol; 2020 Nov 10; 21(1):469. PubMed ID: 33172397 [Abstract] [Full Text] [Related]
13. Early reduction in total cholesterol to high-density lipoprotein cholesterol ratio predicts hydroxychloroquine efficacy in treating IgA nephropathy. Shi Y, Yang T, Feng Y, Li N, Shao Q, Jiang C, Liu J. Ren Fail; 2024 Dec 10; 46(2):2397046. PubMed ID: 39212237 [Abstract] [Full Text] [Related]
14. Long-term renal survival and undetected risk factors of IgA nephropathy in Chinese children-a retrospective 1243 cases analysis from single centre experience. Wu H, Fang X, Xia Z, Gao C, Peng Y, Li X, Zhang P, Kuang Q, Wang R, Wang M. J Nephrol; 2020 Dec 10; 33(6):1263-1273. PubMed ID: 32507961 [Abstract] [Full Text] [Related]
15. Effects of Hydroxychloroquine on Proteinuria in IgA Nephropathy: A Systematic Review and Meta-Analysis. Zhang J, Lu X, Feng J, Li H, Wang S. Biomed Res Int; 2021 Dec 10; 2021():9171715. PubMed ID: 34901280 [Abstract] [Full Text] [Related]
16. Corticosteroid in IgA nephropathy with moderate proteinuria: A retrospective cohort study. Wang Y, Yu J, Jiang Y, Li J, Yimamuyushan A, Xia X, Fan L, Huang F, Chen W, Liu Q. Nephrology (Carlton); 2024 May 10; 29(5):268-277. PubMed ID: 38186010 [Abstract] [Full Text] [Related]
17. Time-Varying Proteinuria and Progression of IgA Nephropathy: A Cohort Study. Tang C, Chen P, Si FL, Lv JC, Shi SF, Zhou XJ, Liu LJ, Zhang H. Am J Kidney Dis; 2024 Aug 10; 84(2):170-178.e1. PubMed ID: 38364955 [Abstract] [Full Text] [Related]
18. Significance of clinical and morphological prognostic risk factors in IgA nephropathy: follow-up study of comparison patient groups with and without renoprotection. Riispere Ž, Kuudeberg A, Seppet E, Sepp K, Ilmoja M, Luman M, Kõlvald K, Auerbach A, Ots-Rosenberg M. BMC Nephrol; 2017 Mar 14; 18(1):89. PubMed ID: 28292274 [Abstract] [Full Text] [Related]
19. Are children with IgA nephropathy different from adult patients? Su B, Jiang Y, Li Z, Zhou J, Rong L, Feng S, Zhong F, Sun S, Zhang D, Xia Z, Feng C, Huang W, Li X, Chen C, Hao Z, Wang M, Qin L, Chen M, Li Y, Ding J, Bao Y, Liu X, Deng F, Cheng X, Zhang L, Zhang X, Yang H, Peng X, Sun Q, Deng L, Jiang X, Xie M, Gao Y, Yu L, Liu L, Gao C, Mao J, Zheng W, Dang X, Xia H, Wang Y, Zhong X, Ding J, Lv J, Zhang H. Pediatr Nephrol; 2024 Aug 14; 39(8):2403-2412. PubMed ID: 38578470 [Abstract] [Full Text] [Related]
20. Corticosteroid therapy in IgA nephropathy with minimal proteinuria and high renal pathological score: A single‑center cohort study. Tang Y, He H, Sun W, Hu P, Chen X, Xu X. Mol Med Rep; 2018 Oct 14; 18(4):4103-4112. PubMed ID: 30132546 [Abstract] [Full Text] [Related] Page: [Next] [New Search]